Med12 is a novel regulator of peripheral myelin maintenance
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Background

Methods
● A previously generated Cre-lox recombination
system was generated in the lab and used to
carry out this study, depicted below

● The CNS did not show severe myelin
loss
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●

Med12 is a subunit of the general
transcriptional mediator complex
○ Mutations of the protein cause various
diseases including FG Syndrome and
Lujan-Fryns Syndrome
All of the diseases listed above cause
myelin abnormalities, often demyelination
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● To test the physical capabilities of the mice, an
inverted cage lid strength test was performed

●

The myelin sheath is the protective,
lipid-rich layer surrounding axons
The loss or degradation of myelin is
accredited to the development of many
neurodegenerative diseases in humans
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● Staining for immunofluorescence was performed on
the corpus callosum and sciatic nerve, using
fluoromyelin and MBP, myelin basic protein, along
with other antibodies

● The PNS did not show differences in
the myelin composition
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Our Research Objectives
The main objective of this study, is to
uncover to what extent, if any, the loss of
Med12 has on the loss of myelin stability in
adult mice.
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Prior Med12 Research
● No research has been done before in
postnatal developing mice to truly
understand the extent Med12 has on
the nervous system and myelination
● This is a unique body of work to
explore that topic for the first time
using this model
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Conclusion
At this point in the research, there is not
enough data to make any concrete
conclusions regarding the role of Med12
on myelination.
Future steps for this study include neural
conduction assays to measure the
velocity/speed of electrical signals and
electron microscopy experiments to
directly analyze myelin ultrastructure.

